Opportunity Overview
The Cancer Prevention and Research Institute of Texas (CPRIT) has opened the FY 2027 Cycle 2 Research Training Award for Workforce Development. The mechanism supports integrated institutional cancer-research training programs designed to expand the skills and expertise of predoctoral trainees, postdoctoral fellows, and/or clinical fellows and to develop the next generation of cancer investigators and research leaders in Texas.
Funding and Application Window
CPRIT lists awards of up to $4 million over five years. The FY 2027 Cycle 2 application window opens September 16, 2026 and closes November 18, 2026. The controlling RFA sets the application receipt opening and closing times; applicants should use the current CPRIT Grant Management Platform and final RFA instructions when submitting.
Program Purpose
The award is intended to build rigorous, integrated training environments that give trainees broad access to cancer-research opportunities across disciplinary lines. CPRIT expects programs to strengthen trainee skills, position participants for independent research careers, and support innovative work with potential impact on cancer prevention, detection, diagnosis, and treatment.
Eligible Institutional Model
The opportunity is designed for Texas-based institutions of higher education or university-system components with the institutional infrastructure, accredited training programs where required, faculty mentor depth, and research environment necessary to operate a multi-year cancer-research training program. The principal investigator must meet the eligibility requirements in the RFA and maintain the required Texas-based appointment and residency during the project.
Strong Application Components
- A clearly defined training theme and multidisciplinary mentor network.
- Transparent trainee recruitment, selection, mentoring, evaluation, and career-development processes.
- Access to high-quality basic, translational, population, or clinical cancer-research opportunities.
- Measurable trainee outcomes and a credible pathway toward independent cancer-research careers.
- Institutional commitment, research resources, and program governance sufficient to sustain a five-year training effort.
Atlas Analysis
This is a substantial healthcare-workforce and research-capacity opportunity with an Atlas Opportunity Score of 93/100. It can strengthen Texas cancer-research pipelines and the future clinical/research workforce, but it is not a direct-vendor equipment grant. N9+ or other clinical technology should only appear when it is genuinely part of an approved research-training environment or research protocol and is allowable under the RFA; the award should not be treated as a general technology-purchase pathway.
Application Readiness
Institutions should verify organizational and principal-investigator eligibility, activate the necessary CPRIT Grant Management Platform accounts, define the trainee populations and research-training structure, document mentor and institutional capacity, build the five-year training and evaluation plan, and prepare the application for the September 16 opening and November 18, 2026 deadline.
Verified source: Cancer Prevention and Research Institute of Texas, FY 2027 Cycle 2 funding opportunities and Research Training Award RFA.